Thursday, April 11, 2024 10:36:10 PM
If you watched Dr. Liau's presentation, did you see how fast the t-cell expansion was and how intense the anti-tumor response was? You need to pick up all the terminologies related to the technologies Dr. Liau adopted for her research and check if all the BPs are hiring researchers with expertise requirement about those technologies.
I listed all these publications and obviously you haven't taken a look. Open each paper and just check the authors to see if you can find the name you are familiar with.
https://www.cell.com/cancer-cell/pdf/S1535-6108(22)00393-2.pdf
https://journals.aai.org/jimmunol/article/184/6/3106/82771
https://www.jci.org/articles/view/40269
https://journals.aai.org/jimmunol/article/192/6/2920/1679
https://rupress.org/jem/article/212/3/351/41764/Immature-myeloid-cells-directly-contribute-to-skin
https://aacrjournals.org/cancerres/article/72/21/5483/576215/Autophagy-Induced-by-Conventional-Chemotherapy
https://journals.aai.org/jimmunol/article/182/1_Supplement/88.26/46487
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM